Resperate is a brand that specializes in the development and distribution of medical devices aimed at managing and reducing high blood pressure. Their flagship product is a non-drug therapy that uses guided breathing to lower blood pressure naturally.
Resperate was launched in 2001 as a result of collaboration between InterCure Ltd and Dr. Erez Gavish of the Technion-Israel Institute of Technology.
The company received clearance from the U.S. Food and Drug Administration (FDA) in 2002 for the sale and marketing of their blood pressure management device.
Over the years, Resperate has gained recognition and has been clinically tested in numerous trials, showing positive results in reducing blood pressure.
In 2010, Resperate was granted an additional FDA clearance for its updated version of the device, which featured more advanced technology.
Resperate is currently a leading brand in the field of non-drug therapy for hypertension, with its devices being distributed globally.
Resperate uses guided breathing techniques to slow down the breathing rate, which, in turn, helps relax blood vessels and lower blood pressure.
Yes, Resperate is safe to use for most individuals. However, it is recommended to consult with a healthcare professional before starting any new medical device.
The effectiveness of Resperate can vary for different individuals. However, many users have reported seeing a reduction in blood pressure within a few weeks of consistent use.
Resperate can be used alongside medication but should not replace prescribed medications without consulting a healthcare professional.
Resperate is suitable for adults of all age groups. However, it is recommended to consult with a healthcare professional if using the device for children or elderly individuals.
